Gilead Sciences has signed a five-year agreement extension with Cognizant to advance its DevOps environment and support the deployment of agentic AI tools across designated technology initiatives.
Source: Pharmaceutical Technology, 2026-10-07. Third-party report, linked to its original publisher; IC360 has not independently verified it.
